Get Premium to unlock powerful stock data
Asensus Surgical Inc logo

Asensus Surgical Inc

$ 0.41 +0.0243 (+6.23%) 10:09 PM EST
P/E:
At Loss
P/B:
0.65
Market Cap:
$ 97.99M
Enterprise V:
$ -282.00K
Volume:
1.66M
Avg Vol (2M):
3.37M
Also Trade In:
Volume:
1.66M
Market Cap $:
97.99M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.37M
Enterprise Value $:
-282.00K
PB Ratio:
0.65
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Asensus Surgical Inc
NAICS : 339112 SIC : 3841
1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703
Description
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. Its single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
Name Current Vs Industry Vs History
Cash-To-Debt 18.97
Equity-to-Asset 0.91
Debt-to-Equity 0.04
Debt-to-EBITDA -0.11
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.44
Distress
Grey
Safe
Beneish M-Score -2.89
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 58.49
9-Day RSI 53.26
14-Day RSI 50.8
6-1 Month Momentum % -58.13
12-1 Month Momentum % -86.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.72
Quick Ratio 12.66
Cash Ratio 11.99
Days Inventory 397.74
Days Sales Outstanding 55.65
Days Payable 112.99

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -141.8

Financials (Next Earnings Date:2022-08-05 Est.)

ASXC's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with AMEX:ASXC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 7.215
EPS (TTM) ($) -0.28
Beta 0.99
Volatility % 28.82
14-Day RSI 50.8
14-Day ATR ($) 0.038713
20-Day SMA ($) 0.411875
12-1 Month Momentum % -86.16
52-Week Range ($) 0.35 - 2.86
Shares Outstanding (Mil) 236.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Asensus Surgical Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More